Search the Roll Call archive by keyword, date, Congress, section, or tags.
The proposed rule from the Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs known as GLP-1 inhibitors, sold as Zepbound, Ozempic, Mounjaro
The Biden administration said those negotiated prices, which take effect Jan. 1, 2026, would have saved Medicare $6 billion if they were in effect last year.
Republican vice presidential candidate Sen. JD Vance of Ohio and the Democratic vice presidential candidate, Minnesota Gov. Tim Walz, participate in a debate at the CBS Broadcast Center on Oct. 1, 2024, in New York City.
CMS announced the price list for the first 10 drugs, with the reduced sticker prices due to take effect on Jan. 1, 2026.
The prices take effect Jan. 1, 2026. President Joe Biden and Vice President Kamala Harris are expected to tout the news at an event in Prince George’s County, Md.
But lawmakers have not acted on the issue this year because of a series of stopgap spending bills, and the cuts took effect Jan. 1.
The agency is expected to send its first offer to the companies Feb. 1, 2024, and finalize negotiations Aug. 1 of next year. Prices would be published Sept. 1, taking effect in 2026.
Greenwood is also waiting to hear back on an application for critical access status — a designation that applies to Ozarks — which would grant the hospital a 1 percent bonus on Medicare claims.
New prices take effect Jan. 1, 2026.
A spokesperson for the Ohio Department of Medicaid said the state aims to have the new program begin Jan. 1. Â
Georges Benjamin, executive director of the American Public Health Association, predicted the deal will mean flat funding or a roughly 1 percent cut across the board in fiscal 2024 for the CDC.
Medicare pays a 1 percent bonus on the theoretical cost of care for critical access hospitals. Greenwood is under the distance threshold for critical access designation.
As part of its annual payment updates to Medicare Advantage plans, CMS proposed earlier this month a 1 percent increase for 2024 — a smaller increase than proposed in past years that is being framed as
Those authorities run through Oct. 1, 2024, but because pharmacists operate largely under state laws, the intersection of federal and state policies will be unclear once the emergency expires in